MCF Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.1M | Buy |
11,665
+1,197
| +11% | +$427K | 0.18% | 66 |
|
|
2025
Q4 | $3.43M | Buy |
10,468
+3,424
| +49% | +$1.09M | 0.19% | 56 |
|
|
2025
Q3 | $1.99M | Buy |
7,044
+1,671
| +31% | +$485K | 0.12% | 61 |
|
|
2025
Q2 | $1.5M | Buy |
5,373
+22
| +0.4% | +$6.23K | 0.1% | 71 |
|
|
2025
Q1 | $1.67M | Sell |
5,351
-62
| -1% | -$18.3K | 0.12% | 60 |
|
|
2024
Q4 | $1.41M | Buy |
5,413
+940
| +21% | +$279K | 0.1% | 66 |
|
|
2024
Q3 | $1.44M | Sell |
4,473
-38
| -0.8% | -$12.4K | 0.1% | 68 |
|
|
2024
Q2 | $1.41M | Buy |
4,511
+203
| +5% | +$59.6K | 0.11% | 66 |
|
|
2024
Q1 | $1.22M | Buy |
4,308
+146
| +4% | +$42.7K | 0.09% | 75 |
|
|
2023
Q4 | $1.2M | Buy |
4,162
+68
| +2% | +$18.5K | 0.1% | 76 |
|
|
2023
Q3 | $1.1M | Buy |
4,094
+70
| +2% | +$17.5K | 0.1% | 73 |
|
|
2023
Q2 | $894K | Buy |
4,024
+21
| +0.5% | +$4.87K | 0.08% | 79 |
|
|
2023
Q1 | $968K | Sell |
4,003
-210
| -5% | -$51.5K | 0.09% | 75 |
|
|
2022
Q4 | $1.11M | Buy |
4,213
+493
| +13% | +$132K | 0.11% | 64 |
|
|
2022
Q3 | $839K | Buy |
3,720
+734
| +25% | +$178K | 0.09% | 74 |
|
|
2022
Q2 | $726K | Sell |
2,986
-15
| -0.5% | -$3.68K | 0.08% | 73 |
|
|
2022
Q1 | $726K | Buy |
+3,001
| New | +$690K | 0.07% | 83 |
|
|
2021
Q4 | – | Sell |
-2,479
| Closed | -$527K | – | 75 |
|
|
2021
Q3 | $527K | Buy |
2,479
+678
| +38% | +$156K | 0.05% | 95 |
|
|
2021
Q2 | $439K | Buy |
1,801
+433
| +32% | +$107K | 0.05% | 100 |
|
|
2021
Q1 | $340K | Buy |
1,368
+169
| +14% | +$40.3K | 0.04% | 117 |
|
|
2020
Q4 | $276K | Hold |
1,199
| – | – | 0.03% | 114 |
|
|
2020
Q3 | $305K | Buy |
1,199
+77
| +7% | +$19.1K | 0.04% | 109 |
|
|
2020
Q2 | $265K | Hold |
1,122
| – | – | 0.04% | 117 |
|
|
2020
Q1 | $227K | Hold |
1,122
| – | – | 0.04% | 127 |
|
|
2019
Q4 | $270K | Hold |
1,122
| – | – | 0.04% | 128 |
|
|
2019
Q3 | $217K | Hold |
1,122
| – | – | 0.04% | 139 |
|
|
2019
Q2 | $207K | Hold |
1,122
| – | – | 0.03% | 140 |
|
|
2019
Q1 | $213K | Hold |
1,122
| – | – | 0.04% | 134 |
|
|
2018
Q4 | $218K | Hold |
1,122
| – | – | 0.04% | 124 |
|
|
2018
Q3 | $233K | Hold |
1,122
| – | – | 0.04% | 119 |
|
|
2018
Q2 | $207K | Sell |
1,122
-77
| -6% | -$13.6K | 0.04% | 122 |
|
|
2018
Q1 | $204K | Hold |
1,199
| – | – | 0.04% | 121 |
|
|
2017
Q4 | $208K | Hold |
1,199
| – | – | 0.04% | 118 |
|
|
2017
Q3 | $224K | Hold |
1,199
| – | – | 0.04% | 103 |
|
|
2017
Q2 | $206K | Sell |
1,199
-450
| -27% | -$73.2K | 0.04% | 97 |
|
|
2017
Q1 | $271K | Buy |
1,649
+573
| +53% | +$95.2K | 0.06% | 82 |
|
|
2016
Q4 | $157K | Buy |
1,076
+974
| +955% | +$147K | 0.03% | 111 |
|
|
2016
Q3 | $17K | Sell |
102
-11
| -10% | -$1.86K | ﹤0.01% | 284 |
|
|
2016
Q2 | $17K | Buy |
113
+37
| +49% | +$5.75K | ﹤0.01% | 310 |
|
|
2016
Q1 | $11K | Buy |
76
+1
| +1% | +$149 | ﹤0.01% | 307 |
|
|
2015
Q4 | $12K | Hold |
75
| – | – | ﹤0.01% | 305 |
|
|
2015
Q3 | $10K | Buy |
+75
| New | +$11.8K | ﹤0.01% | 312 |
|
Other funds holding AMGN
VCM
VPM
MCF Advisors's AMGN Position: Q1 2026 in Review
MCF Advisors increased its Amgen (AMGN) stake by 11% in Q1 2026, buying an estimated $427K and bringing the position to 11,665 shares worth $4.1M. The position accounts for 0.18% of the portfolio, ranked #66.
MCF Advisors first reported a position in AMGN in Q3 2015 and has held it in 42 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- MCF Advisors held 11,665 shares of Amgen worth $4.1M as of Q1 2026.
- MCF Advisors bought 1,197 Amgen shares in Q1 2026, an estimated $427K.
- Amgen made up 0.18% of MCF Advisors's portfolio in Q1 2026, its #66 holding.
- MCF Advisors first reported a position in Amgen in Q3 2015 and has held it in 42 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.